News
CAR T cells rescue younger children with relapsed/refractory ALL
- Author:
- Neil Osterweil
Children younger than 3 years with relapsed/refractory acute lymphoblastic leukemia had CAR T therapy outcomes similar to those of older children...
News
Experimental antibody-drug conjugate shown active against r/r DLBCL
- Author:
- Neil Osterweil
The experimental antibody-drug conjugate naratuximab targets CD37, a surface marker on most B-cell lymphoma...
News
Promising HER2+/HR– breast cancer survival with de-escalated therapy
- Author:
- Neil Osterweil
Dual HER2 blockade and paclitaxel therapy was associated with excellent overall and invasive disease-free...
News
GLOW: Ibrutinib+venetoclax shines in first line for CLL/SLL
- Author:
- Neil Osterweil
Fixed-duration therapy with the combo was associated with high progression-free survival and undetectable...
News
CRC screening guidelines: 45 is the new 50, and 85 is the new 75
- Author:
- Neil Osterweil
Multiple guidelines, levels of evidence, different screening methods with varying efficacy, individual risk factors - how can clinicians make...
News
CONCERT: Better QoL but not survival with cabazitaxel in metastatic HER2– breast cancer
- Author:
- Neil Osterweil
Sensory peripheral neuropathy was significantly less frequent with cabazitaxel every 3 weeks than with weekly...
News
Genomic signature predicts safety of omitting RT in early breast cancer
- Author:
- Neil Osterweil
Patients categorized as low risk who did not undergo radiation had a 10-year locoregional recurrence rate of 7...
News
ACE inhibitor prevents trastuzumab-associated LVEF decline after anthracyclines in BC treatment
- Author:
- Neil Osterweil
The rate of left ventricular ejection fraction declines below 50% in patients on anthracyclines and trastuzumab...
News
Pregnancy effect on chemotherapy does not affect maternal breast cancer outcomes
- Author:
- Neil Osterweil
There were no significant differences in survival outcomes between pregnant women with breast cancer and...
News
Collaborative effort reduces COPD readmissions, costs
- Author:
- Neil Osterweil
A joint performance-improvement initiative helped reduce COPD-related ED visits and readmissions within 30 days...
News
IL-6 levels predict distant breast cancer recurrence
- Author:
- Neil Osterweil
If validated in further studies, IL-6 levels could be a biomarker for response to therapies targeting...
News
Venetoclax shows activity against T-ALL in children
- Author:
- Neil Osterweil
Patients with T-lineage acute lymphoblastic leukemia (4/7) in a small retrospective study had complete responses...
News
COPD in younger adults deadlier than expected
- Author:
- Neil Osterweil
The mortality rate for younger adults with COPD was five times higher than that of their peers without COPD....
News
Patients with moderate COPD also benefit from triple therapy
- Author:
- Neil Osterweil
The benefits of triple-therapy seen in the ETHOS trial were not limited to patients with severe COPD, a subanalysis shows.
News
Sex differences in COPD symptoms predict cardiac comorbidity
- Author:
- Neil Osterweil
“Our findings give hints how diagnostic information might be used differently in men and women.”